Literature DB >> 1920376

False positive results with immunoreactive trypsinogen screening for cystic fibrosis owing to trisomy 13.

F J Priest, N C Nevin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1920376      PMCID： PMC1016991          DOI： 10.1136/jmg.28.8.575-a

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  4 in total

1.  Cystic fibrosis in Northern Ireland.

Authors:  G B Nevin; N C Nevin; A O Redmond
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

2.  Fetal abnormalities in cystic fibrosis suggest a deficiency in proteolysis of cholecystokinin.

Authors:  C M Gosden; J R Gosden
Journal:  Lancet       Date:  1984-09-08       Impact factor: 79.321

3.  Trisomy 18, cystic fibrosis, and blood immunoreactive trypsin.

Authors:  A F Heeley; D G Fagan
Journal:  Lancet       Date:  1984-01-21       Impact factor: 79.321

4.  Screening for cystic fibrosis: a four year regional experience.

Authors:  G Roberts; M Stanfield; A Black; A Redmond
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791
  4 in total
  2 in total

1.  False-positive results in neonatal screening for cystic fibrosis based on a three-stage protocol (IRT/DNA/IRT): Should we adjust IRT cut-off to ethnic origin?

Authors:  D Cheillan; M Vercherat; F Chevalier-Porst; M Charcosset; M O Rolland; C Dorche
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Differences in immunoreactive trypsin values between type of feeding and ethnicity in neonatal cystic fibrosis screening: a cross-sectional study.

Authors:  Ernesto Cortés; Ana María Roldán; Antonio Palazón-Bru; María Mercedes Rizo-Baeza; Herminia Manero; Vicente Francisco Gil-Guillén
Journal:  Orphanet J Rare Dis       Date:  2014-11-07       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.